Thiazolidinediones

N Engl J Med. 2004 Sep 9;351(11):1106-18. doi: 10.1056/NEJMra041001.
No abstract available

Publication types

  • Review

MeSH terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism
  • Biomarkers
  • Cardiovascular Diseases / physiopathology
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Fatty Liver / drug therapy
  • Female
  • Gene Expression Regulation
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance / physiology*
  • Lipodystrophy / drug therapy
  • Polycystic Ovary Syndrome / drug therapy
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Risk Factors
  • Thiazolidinediones / adverse effects
  • Thiazolidinediones / pharmacology
  • Thiazolidinediones / therapeutic use*
  • Transcription Factors / metabolism*

Substances

  • Biomarkers
  • Hypoglycemic Agents
  • Receptors, Cytoplasmic and Nuclear
  • Thiazolidinediones
  • Transcription Factors